FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3164753345> ?p ?o ?g. }

• W3164753345 abstract "131 I-meta-iodobenzylguanidine (131 I-MIBG) is effective in relapsed neuroblastoma. The Children's Oncology Group (COG) conducted a pilot study (NCT01175356) to assess tolerability and feasibility of induction chemotherapy followed by 131 I- MIBG therapy and myeloablative busulfan/melphalan (Bu/Mel) in patients with newly diagnosed high-risk neuroblastoma.Patients with MIBG-avid high-risk neuroblastoma were eligible. After the first two patients to receive protocol therapy developed severe sinusoidal obstruction syndrome (SOS), the trial was re-designed to include an 131 I-MIBG dose escalation (12, 15, and 18 mCi/kg), with a required 10-week gap before Bu/Mel administration. Patients who completed induction chemotherapy were evaluable for assessment of 131 I-MIBG feasibility; those who completed 131 I-MIBG therapy were evaluable for assessment of 131 I-MIBG + Bu/Mel feasibility.Fifty-nine of 68 patients (86.8%) who completed induction chemotherapy received 131 I-MIBG. Thirty-seven of 45 patients (82.2%) evaluable for 131 I-MIBG + Bu/Mel received this combination. Among those who received 131 I-MIBG after revision of the study design, one patient per dose level developed severe SOS. Rates of moderate to severe SOS at 12, 15, and 18 mCi/kg were 33.3%, 23.5%, and 25.0%, respectively. There was one toxic death. The 131 I-MIBG and 131 I-MIBG+Bu/Mel feasibility rates at the 15 mCi/kg dose level designated for further study were 96.7% (95% CI: 83.3%-99.4%) and 81.0% (95% CI: 60.0%-92.3%).This pilot trial demonstrated feasibility and tolerability of administering 131 I-MIBG followed by myeloablative therapy with Bu/Mel to newly diagnosed children with high-risk neuroblastoma in a cooperative group setting, laying the groundwork for a cooperative randomized trial (NCT03126916) testing the addition of 131 I-MIBG during induction therapy." @default.
• W3164753345 created "2021-06-07" @default.
• W3164753345 creator A5000459362 @default.
• W3164753345 creator A5004642111 @default.
• W3164753345 creator A5008628156 @default.
• W3164753345 creator A5017279874 @default.
• W3164753345 creator A5017501517 @default.
• W3164753345 creator A5017840054 @default.
• W3164753345 creator A5024010972 @default.
• W3164753345 creator A5027535646 @default.
• W3164753345 creator A5030496565 @default.
• W3164753345 creator A5036062620 @default.
• W3164753345 creator A5040815350 @default.
• W3164753345 creator A5041707000 @default.
• W3164753345 creator A5050598852 @default.
• W3164753345 creator A5059358967 @default.
• W3164753345 creator A5072874640 @default.
• W3164753345 creator A5077440294 @default.
• W3164753345 creator A5077823988 @default.
• W3164753345 creator A5078499837 @default.
• W3164753345 creator A5079832945 @default.
• W3164753345 creator A5084871192 @default.
• W3164753345 date "2021-05-24" @default.
• W3164753345 modified "2023-10-06" @default.
• W3164753345 title "A safety and feasibility trial of ¹³¹ I‐MIBG in newly diagnosed high‐risk neuroblastoma: A Children's Oncology Group study" @default.
• W3164753345 cites W1101533912 @default.
• W3164753345 cites W1561744319 @default.
• W3164753345 cites W1907616122 @default.
• W3164753345 cites W191238808 @default.
• W3164753345 cites W1944076654 @default.
• W3164753345 cites W1982238493 @default.
• W3164753345 cites W1994940008 @default.
• W3164753345 cites W2005446804 @default.
• W3164753345 cites W2023282431 @default.
• W3164753345 cites W2029590939 @default.
• W3164753345 cites W2038252730 @default.
• W3164753345 cites W2046209641 @default.
• W3164753345 cites W2054524692 @default.
• W3164753345 cites W2077242620 @default.
• W3164753345 cites W2096398040 @default.
• W3164753345 cites W2116195296 @default.
• W3164753345 cites W2118171008 @default.
• W3164753345 cites W2120781745 @default.
• W3164753345 cites W2127775057 @default.
• W3164753345 cites W2130465135 @default.
• W3164753345 cites W2136462971 @default.
• W3164753345 cites W2159103399 @default.
• W3164753345 cites W2159407642 @default.
• W3164753345 cites W2168240861 @default.
• W3164753345 cites W2323995621 @default.
• W3164753345 cites W2346075579 @default.
• W3164753345 cites W2592061165 @default.
• W3164753345 cites W2754541706 @default.
• W3164753345 cites W2758777848 @default.
• W3164753345 cites W2797606437 @default.
• W3164753345 cites W2920028822 @default.
• W3164753345 cites W2935510920 @default.
• W3164753345 cites W2971319283 @default.
• W3164753345 cites W3094521384 @default.
• W3164753345 cites W4293241248 @default.
• W3164753345 cites W4321509052 @default.
• W3164753345 doi "https://doi.org/10.1002/pbc.29117" @default.
• W3164753345 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34028986" @default.
• W3164753345 hasPublicationYear "2021" @default.
• W3164753345 type Work @default.
• W3164753345 sameAs 3164753345 @default.
• W3164753345 citedByCount "12" @default.
• W3164753345 countsByYear W31647533452019 @default.
• W3164753345 countsByYear W31647533452021 @default.
• W3164753345 countsByYear W31647533452022 @default.
• W3164753345 countsByYear W31647533452023 @default.
• W3164753345 crossrefType "journal-article" @default.
• W3164753345 hasAuthorship W3164753345A5000459362 @default.
• W3164753345 hasAuthorship W3164753345A5004642111 @default.
• W3164753345 hasAuthorship W3164753345A5008628156 @default.
• W3164753345 hasAuthorship W3164753345A5017279874 @default.
• W3164753345 hasAuthorship W3164753345A5017501517 @default.
• W3164753345 hasAuthorship W3164753345A5017840054 @default.
• W3164753345 hasAuthorship W3164753345A5024010972 @default.
• W3164753345 hasAuthorship W3164753345A5027535646 @default.
• W3164753345 hasAuthorship W3164753345A5030496565 @default.
• W3164753345 hasAuthorship W3164753345A5036062620 @default.
• W3164753345 hasAuthorship W3164753345A5040815350 @default.
• W3164753345 hasAuthorship W3164753345A5041707000 @default.
• W3164753345 hasAuthorship W3164753345A5050598852 @default.
• W3164753345 hasAuthorship W3164753345A5059358967 @default.
• W3164753345 hasAuthorship W3164753345A5072874640 @default.
• W3164753345 hasAuthorship W3164753345A5077440294 @default.
• W3164753345 hasAuthorship W3164753345A5077823988 @default.
• W3164753345 hasAuthorship W3164753345A5078499837 @default.
• W3164753345 hasAuthorship W3164753345A5079832945 @default.
• W3164753345 hasAuthorship W3164753345A5084871192 @default.
• W3164753345 hasBestOaLocation W31647533452 @default.
• W3164753345 hasConcept C126322002 @default.
• W3164753345 hasConcept C143998085 @default.
• W3164753345 hasConcept C197934379 @default.
• W3164753345 hasConcept C2776611710 @default.
• W3164753345 hasConcept C2776694085 @default.
• W3164753345 hasConcept C2776715637 @default.
• W3164753345 hasConcept C2778375690 @default.

• next